GW Pharmaceuticals to Present at the Goldman Sachs 38th Annual …

LONDON, June 07, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that GW management will present at the Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, 14 June at 11:20 a.m. (PDT) at the Terranea Resort, Rancho Palos Verdes, CA.  

A live audio webcast of the presentation will be available through GW’s corporate website in the investor relations section from the investor’s calendar of events page at www.gwpharm.com. A replay will be available soon after the live presentation.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad

... read more at: http://www.nasdaq.com/press-release/gw-pharmaceuticals-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-on-14-20170607-00914